Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 8, 836 (1 November 2009) | doi:10.1038/nrd3038
Deal watch: Nektar in US|[dollar]|1.5 billion licensing deal with AstraZeneca
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
